Fit to Function: Special friendships develops at local adaptive, inclusive gym
Anthony has worked out his entire life even though he lives daily dealing with a rare, genetic, and usually fatal disorder called Freedrichs Ataxia.
Grace Therapeutics Announces Third Fiscal Quarter 2025 Financial Results, Provides Business Update
Announced Phase 3 STRIVE-ON Safety Trial Met Primary Endpoint and Provided Clinical Benefit Compared to Orally Administered Nimodipine; New Drug ...
Medscape6d
Successful Implementation of the National Institutes of Health Stroke Scale on a Stroke/Neurovascular Unit
Stroke-related neurological changes can occur ... Identification of motor weakness and ataxia can alert the staff to fall risk (Spilker et al., 1997). Despite evidence that the NIHSS is valid ...
"I Think He's In There": After 10 Months Of Being Unable To Move Or Speak, Doctors Realized This Man Was Awake The Whole Time
"During this time, I realized there was something scarier than death. I thought I might be stuck like this forever." ...
Grace Therapeutics, Inc.: Grace Therapeutics Announces Third Fiscal Quarter 2025 Financial Results, Provides Business Update
Announced Phase 3 STRIVE-ON Safety Trial Met Primary Endpoint and Provided Clinical Benefit Compared to Orally Administered Nimodipine; New Drug Application (NDA) Submission Anticipated First Half of ...
Grace Therapeutics Announces Results From Pivotal Phase 3 STRIVE-ON Safety Trial of GTx-104 in aSAH
Trial Met the Primary Endpoint and Provides Evidence of GTx-104 Clinical Benefit Compared to Orally Administered NimodipineNew Drug Application ...
Zeen® Revolutionizes Mobility: Empowering Disabled Users To Sit, Stand, Walk, And Coast, Virtually Eliminating Fall Risk
Innovative Device Bridges the Gap Between Walkers and Wheelchairs with Over 1,000 Units Sold and Growing PHILADELPHIA, PA, UNITED STATES, J ...
Grace Therapeutics, Inc.: Grace Therapeutics Announces Results From Pivotal Phase 3 STRIVE-ON Safety Trial of GTx-104 in aSAH
Trial Met the Primary Endpoint and Provides Evidence of GTx-104 Clinical Benefit Compared to Orally Administered Nimodipine New Drug Application (NDA) Submission Expected in the First Half of 2025 PRI ...
BMJ16d
The use of FAST and ABCD2 scores in posterior circulation, compared with anterior circulation, stroke and transient ischemic attack
Correspondence to Dr Giosuè Gulli, Clinical Neuroscience, St George's University of London, Cranmer Terrace, London, SW17 0RE, UK; ggulli{at}sgul.ac.uk Symptoms and signs associated with posterior ...
Frontiers24d
Molecular Biomarkers in the Prediction, Diagnosis, and Prognosis of Neurodegenerative Diseases
The discovery and deployment of biomarkers for neurodegenerative diseases, such as Alzheimer's disease and related disorders, Parkinson's disease, ataxia, stroke, Huntington's disease, diabetic ...
The Altamont Enterprise11d
State says risk to public ‘remains low’ as bird flu evolves
Governor Kathy Hochul announced this week the temporary closure of all live bird markets in several downstate counties after seven different markets found positive cases of bird flu, which has been ...
MyChesCo on MSN14d
Revolutionary Mobility Device Zeen Honored as One of Time’s Best Inventions
Zeen®, an innovative mobility aid designed to provide independence and freedom, has been transforming lives since its launch in the United States. Developed by Hall-of-Fame inventor and Oscar ...